日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The path forward for T cell engagers in patients with prostate cancer

T细胞衔接器在治疗前列腺癌患者中的应用前景

Subudhi, Sumit K; Siddiqui, Bilal A; Zarrabi, Kevin K; Kelly, William K; Drake, Charles G

Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance

开发一种靶向富含亮氨酸重复序列蛋白15的放射免疫治疗诊断方法,以消除促肿瘤发生机制和免疫治疗耐药性。

Storey, Claire M; Altai, Mohamed; Lückerath, Katharina; Zedan, Wahed; Zhu, Henan; Breuer, Lara; Trajkovic-Arsic, Marija; Park, Julie; Hasson, Abbie; Siveke, Jens; Abou, Diane; Marks, Haley; Ulmert, Enna; Ridley, Alexander; Safi, Marcella; Lamminmäki, Urpo; Yuen, Constance; Geres, Susanne; Mao, Liqun; Cheng, Michael; Subudhi, Sumit K; Siddiqui, Bilal A; Federman, Noah; Czernin, Johannes; Herrmann, Ken; Bentolila, Laurent; Yang, Xia; Graeber, Thomas G; Damoiseaux, Robert; Thorek, Daniel; Ulmert, David

Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols

癌症免疫治疗学会 (SITC) 关于免疫治疗临床方案关键生物标志物的共识声明

Cottrell, Tricia R; Lotze, Michael T; Ali, Alaa; Bifulco, Carlo B; Capitini, Christian M; Chow, Laura Q M; Cillo, Anthony R; Collyar, Deborah; Cope, Leslie; Deutsch, Julie Stein; Dubrovsky, Genia; Gnjatic, Sacha; Goh, Denise; Halabi, Susan; Kohanbash, Gary; Maecker, Holden T; Maleki Vareki, Saman; Mullin, Sarah; Seliger, Barbara; Taube, Janis; Vos, Wim; Yeong, Joe; Anderson, Kristin G; Bruno, Tullia C; Chiuzan, Codruta; Diaz-Padilla, Ivan; Garrett-Mayer, Elizabeth; Glitza Oliva, Isabella C; Grandi, Paola; Hill, Elizabeth G; Hobbs, Brian P; Najjar, Yana G; Pettit Nassi, Phyllis; Simons, Virgil H; Subudhi, Sumit K; Sullivan, Ryan J; Takimoto, Chris H

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PORTER研究的临床和转化结果:一项针对转移性去势抵抗性前列腺癌的联合免疫疗法多队列I期平台试验

Galsky, Matthew D; Autio, Karen A; Cabanski, Christopher R; Wentzel, Kristopher; Graff, Julie N; Friedlander, Terence W; Howes, Timothy R; Shotts, Kristin M; Densmore, Julie; Spasic, Marko; Da Silva, Diane M; Chen, Richard O; Lata, Jennifer; Skolnik, Jeffrey; Keler, Tibor; Yellin, Michael J; LaVallee, Theresa M; Fairchild, Justin; Boffo, Silvia; O'Donnell-Tormey, Jill; Dugan, Ute; Bhardwaj, Nina; Subudhi, Sumit K; Fong, Lawrence

Safety, Efficacy, and Adjacent-level Fracture Risk Following Vertebral Augmentation and Radiofrequency Ablation for the Treatment of Spine Metastases in Patients with Cancer

椎体增强联合射频消融治疗癌症脊柱转移瘤患者的安全性、有效性及邻近节段骨折风险

Stringam, Jeremiah; Pal, Koustav; Niekamp, Andrew; Jiwani, Rahim; Paolucci, Iwan; Kuban, Joshua D; Metwalli, Zeyad; Huang, Steven; Habibollahi, Peiman; Chen, Stephen; Yevich, Steven; Patel, Milan; Subudhi, Sumit K; Campbell, Matthew; Ghia, Amol; Tatsui, Claudio; Sheth, Rahul A

Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer

在寡转移性激素敏感性前列腺癌中整合全身治疗和转移灶靶向治疗

Shi, Xiaolei; Wang, Jarey H; Chapin, Brian F; Aparicio, Ana; Subudhi, Sumit K; Tran, Phuoc T; Park, Ryan J; Deek, Matthew P; Zhang, Hong; Bylund, Kevin C; Cummings, Micheal; Armstrong, Andrew J; Tang, Chad; Sutera, Philip

Subclonal mutation load predicts survival and response to immunotherapy in cancers with low to moderate tumor mutation burden

亚克隆突变负荷可预测低至中等肿瘤突变负荷癌症患者的生存期和免疫治疗反应。

Jiang, Yujie; Montierth, Matthew D; Yu, Kaixian; Ji, Shuangxi; Tran, Quang; Liu, Xiaoqian; Lal, Jessica C; Guo, Shuai; Wu, Aaron; Dai, Yaoyi; Shin, Seung Jun; Li, Ruonan; Cao, Shaolong; Tang, Yuxin; Lesluyes, Tom; Kopetz, Scott; Msaouel, Pavlos; Sood, Anil K; Devonshire, Ginny; Jones, Christopher M; Ajani, Jaffer; Subudhi, Sumit K; Aparicio, Ana; Sharma, Padmanee; Shen, John Paul; Kimmel, Marek; Wang, Jennifer R; Tarabichi, Maxime; Fitzgerald, Rebecca C; Zhu, Hongtu; Loo, Peter Van; Wang, Wenyi

Continuous Androgen Deprivation Therapy with or Without Metastasis-directed Therapy for Oligometastatic Prostate Cancer: The Multicenter Phase 2 Randomized EXTEND Trial

持续雄激素剥夺疗法联合或不联合转移灶靶向治疗寡转移性前列腺癌:多中心 II 期随机 EXTEND 试验

Sherry, Alexander D; Siddiqui, Bilal A; Haymaker, Cara; Fellman, Bryan M; Medina-Rosales, Marina N; Bathala, Tharakeswara K; Wang, Shuqi; Liu, Suyu; Seo, Aaron; Hara, Kieko; Lu, Hsinyi; Troncoso, Patricia; Chun, Stephen G; Ha, Chul S; Mayo, Lauren L; Mok, Henry; Park, Ryan J; Chapin, Brian F; Phillips, Ryan M; Deek, Matthew P; Kovitz, Craig A; Aparicio, Ana; Zurita, Amado J; Pilie, Patrick G; Cohen, Lorenzo; Choi, Seungtaek L; Reuben, Alexandre; Tran, Phuoc T; Corn, Paul G; Subudhi, Sumit K; Tang, Chad

Development of a Strategic Initiative at MD Anderson Cancer Center to Improve Outcomes in Immune-Related Adverse Events

MD安德森癌症中心制定战略计划,以改善免疫相关不良事件的治疗效果

Fayle, Sarah E; Palaskas, Nicolas L; Siddiqui, Bilal A; McQuade, Jennifer L; Lin, Jamie S; Subudhi, Sumit K; Patel, Anisha B; Jenq, Robert R; Shah, Amishi Y; Spelman, Amy R; Sun, Mianen; Marble, Bettina H; Wang, Yinghong

PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial

PSCA靶向BPX-601 CAR T细胞经rimiducid药理激活后治疗转移性胰腺癌和前列腺癌:一项I期剂量递增试验

Stein, Mark N; Dumbrava, Ecaterina E; Teply, Benjamin A; Gergis, Usama S; Guiterrez, Martin E; Reshef, Ran; Subudhi, Sumit K; Jacquemont, Céline F; Senesac, Joseph H; Bayle, J Henri; Scripture, Charity D; Chatwal, Monica S; Bilen, Mehmet A; Stadler, Walter M; Becerra, Carlos R